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Abstract:
Purpose:
Bloodstream infections are a general cause of death among hospitalized patients. Rapid diagnosis and timely treatment can reduce mortality. The
aim of this investigation was to evaluate the 23S rRNA PCR assays as a rapid detection method for diagnose of sepsis in patients with suspected
bacteremia.
Methods:
A cross-sectional study was conducted at Shahid Beheshti University Hospital in Kashan from November 2017 to December 2018. The blood
samples of 265 patients with suspected bacteremia were studied by blood culture and 23S rRNA PCR techniques. The results were analyzed using
SPSS version 16 and Chi-square test.
Results:
Eighty (30.2%) blood samples of 265 suspected patients, were identified as positive by PCR assays, whereas 27 (10.2%) were identified as positive
by the blood culture technique. The statistical analysis showed a significant association between the results of PCR assays and blood culture and
factors such as prior antibiotic use and underlying diseases (P ˂0.05). Also a significant correlation was observed between laboratory and clinical
criteria and the results of both PCR assays and blood culture (P ˂ 0.05).
Conclusion:
The 23S rRNA PCR method is a rapid and sensitive technique specially for diagnosing sepsis among patients in whom bacteremia is difficult to
diagnose with culture method including neonates and patients who have taken antibiotics before microbial culture.
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1. INTRODUCTION
Bloodstream  Infections  (BSIs)  are  the  second  cause  of
death  among  patients  who  are  hospitalized  in  the  Intensive
Care Unit (ICU) [1]. The mortality rates due to blood stream
infections vary in  different  parts  of the world and range  from
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20-70 percent [2 - 4]. Despite the fact that sepsis was known
2000 years ago, but the definition of it is still challenging for
clinicians  and  there  is  no  'gold  standard'  in  this  context.
Therefore  for  evaluation  of  the  intensity  of  sepsis,  a  reliable
method is needed. The availability of standard guidance helps
clinicians  to  better  manage  patients  and  increase  patient
survival  [5].  The  presence  of  an  infection  and  two  or  more
Systemic  Inflammatory  Response  Syndrome  (SIRS)  criteria
including (respiratory rate more than 20 breaths/minute, heart
rate more than 90 beats/minute, leukopenia or leukocytosis and
102   The Open Microbiology Journal, 2019, Volume 13 Firoozeh et al.
fever  or  hypothermia)  were  used  to  define  sepsis  previously
[6].  Recently  sepsis  has  been  redefined  using  a  new  set  of
criteria  included  in  the  quick  Sepsis-Related  Organ  Failure
Assessment  (qSOFA)  criteria.  According  to  the  Surviving
Sepsis  Campaign  (SSC),  qSOFA  criteria  is  a  tool  for  the
distinction of patients who are at higher risk of death or long-
term hospitalization in ICU. The presence of two out of three
qSOFA  criteria  including:  (altered  mental  status,  systolic
arterial  blood  pressure  less  than  or  equal  to 100  mmHg,  and
respiratory rate greater than or equal to 21 breaths/minute) are
associated with high risk of death [6]. Bacteria are recognized
as  the  main  causes  of  BSIs  [7].  Gram-positive  bacteria  have
been  recognized  as  the  most  common  causes  of  BSIs  and
include 30-50% of all cases of bloodstream infections whereas
25-30% of these infections are due to gram-negative bacteria
[8]. Although the gold standard method for the identification of
bloodstream infections is blood culture method but this method
has several limitations [9].  One of the main problems of this
approach is that the time needed for identification is too long (2
days or  more),  also blood culture  has  low sensitivity  [10].  It
has  been  documented  that  only  about  34%  of  cases  of
nosocomial bacteremia are detected with blood culture [10].
A  series  of  rapid  and  sensitive  molecular  methods  have
been  introduced  for  rapid  detection  of  a  wide  range  of
pathogenic  bacteria  directly  in  blood  specimens  [11].  The
molecular methods have the ability to rapidly identify infective
bacteria  even  if  the  patient  has  taken  antibiotics  [12].  These
useful  methods  have  the  potential  to  reduce  mortality  rates,
duration of hospitalization and ICU stays due to the shortened
time of detection, and identify the pathogenic bacteria which
are missed by blood culture [10]. The aim of the current survey
was to speed the diagnostic trend and detection of the bacterial
causes of BSIs directly in the whole blood samples using 23S
rRNA PCR assays and compare the results obtained with the
results of standard blood culture.
2. METHODS
2.1. Patients
This  cross-sectional  study  was  performed in  the  ward  of
the Infectious Diseases at Shahid Beheshti University Hospital
in Kashan from November 2017 to December 2018 and a total
of 265 patients were studied. Criteria for selection of patients
for  the  study  included  hospitalized  patients  with  fever  (>
38°C), respiratory rate (> 20 breaths/ minute), and white blood
count  (WBC) more than 12,000/mm3  or  less  than 4000/mm3.
Demographic information of the patients including age, gender,
prior antibiotic use, and underlying diseases was obtained by
filling questionnaires and informed consent was obtained from
all patients or their parents.
2.2. Sample Collection
For blood culture, blood samples were obtained from the
catheter  blood  of  patients  at  the  onset  of  fever  prior  to  the
initiation of antimicrobial therapy. For PCR assay, 4 ml blood
in EDTA (VACUETTE®  K3EDTA TUBE, Greiner  Bio-One,
USA)  was  used  which  was  obtained  from  the  same  catheter
blood and was sent within 1-2 hours to Research Laboratory at
the Kashan University of Medical Sciences and stored at 4°C
until  use.  A  Bactec  9050  (Becton  Dickinson,  Sparks,  MD)
automated blood culture system was used. Blood samples were
inoculated into aerobic and anaerobic Bactec bottles and were
incubated at 35°C for 7 days. Bottles were studied with gram
staining and then sub-cultured. Bacterial isolates from positive
bottles were identified by standard bacteriological tests [13].
2.3. PCR Assays
DNA  extraction  from  the  EDTA  whole  blood  tube  was
done using DNA Blood Mini Kit (QIAamp DNA Blood Mini
KitQiagen,  Germany)  according  to  the  protocol  of  the
manufacturer. The Optical Density (OD) of the extracted blood
DNA was  measured  by  spectrophotometry  method  using  the
NanoDrop (BioTek Epoch Microplate). The confirmed extrac-
ted DNA was stored at -20°C until PCR assay. For the DNA
amplification  and  PCR assay,  the  thermal  cycler  (Eppendorf
master cycler®, MA) was applied and the reaction mixture had
a total volume of 50 µL. Thermal program of the PCR assays
contained  initial  denaturation  at  95°C  for  5  min;  35  cycles
including 30 sec at 95°C, 1 min at 58°C, 1 min at 72°C; and
finally 10 min at 72°C for final extension. The conserved 23S
rRNA gene of  the  bacteria  and specific  primers  including:  F
(5′-TCGCTCAACGGATAAAAG-3´)  and  R  (5′-GATGAn-
CCGACATCGAGGTGC-3´)  were  used  [14].  Positive  and
negative  controls  were  included  for  each  PCR  reaction.
2.4. Statistical Analysis
All  statistical  analyses  were  carried  out  using  SPSS  for
windows version 16.0. Statistical evaluation was performed by
Chi-square test and P < 0.05 was considered significant
3. RESULTS
Of 265 hospitalized patients suspected to have BSIs, only
27 (10.2%) showed positive blood culture.  Of these patients,
117  (44.2%)  were  females  and  148  (55.8%)  were  males  and
their ages ranged from 2 months to 96 years with the mean age
of 68.1 years. One hundred and twenty eight (48.3%) patients
had  an  underlying  disease  including  47  (17.7%)  having  dia-
betes  mellitus,  22  (8.3%)  having  kidney  failure,  13  (4.9%)
having  respiratory  failure,  30  (11.3%)  having  infectious
disease, 14 (5.3%) having malignancies, and 2 (0.8%) hospi-
talized infants in NICU (Neonatal Intensive Care Unit) (Table
1). Of 27 patients with positive blood culture, 22 (81.5%) were
of age 60 years or more. Of all patients, 110 (41.5%) received
empirical  antibiotic  treatment.  The  PCR  assays  using  23S
rRNA genes identified 80 (30.2%) of all patients with BSIs. Of
27  blood  culture  positive  samples,  24  (88.9%)  were  found
positive  by  PCR  assays  including  (6  coagulase-negative
staphylococci, 6 Staphylococcus aureus, 5 Escherichia coli, 3
Enterococcus spp. 3 Acinetobacter baumannii, and 1 Klebsiella
pneumoniae)  whereas  3  blood  culture  positive  samples  were
PCR  negative  which  were  identified  as  coagulase-negative
staphylococci.  Forty-nine  patients  among  80  PCR  positive
patients (61.3%) have had prior antibiotic use. The results of
the  statistical  analysis  revealed  a  significant  association  bet-
ween the results of PCR assays and blood culture and factors
such  as  prior  antibiotic  use  and  the  underlying  disease  (P  ˂
0.05)  (Table  1).  Also,  there  was  a  significant  correlation
between  laboratory  and  clinical  criteria  of  patients  such  as
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WBC, C-reactive protein (CRP),  ESR (Erythrocyte sedimen-
tation rate) and fever and the results of both PCR assays and
blood culture (P ˂ 0.05) (Table 2).
4. DISCUSSION
BSIs  is  one  of  the  most  important  causes  of  mortality
among hospitalized patients [15]. Rapid diagnosis and proper
treatment  of  this  infection could be effective in  reducing the
mortality rate associated with bloodstream infections [15]. In
the  present  study,  we  used  23S  rRNA PCR assays  for  rapid
diagnosis of bacteremia in patients with suspected bloodstream
infections. The results obtained were compared to the results of
blood culture. Previous studies showed that the amplification
of conserved genes such as 23S rRNA and 16S rRNA genes is
an accepted method for the detection of bacterial pathogens in
blood samples of patients with bacteremia [7]. The results of
PCR assays using 23S rRNA gene revealed that of all patients
with  suspected  BSIs  30.2%  had  bacteremia.  In  a  report  in
Germany  on  342  blood  samples  of  patients  with  suspected
sepsis, 25.7% had positive PCR results using 16S rRNA gene
[7].  In  other  studies  in  China  and  Egypt,  from  172  and  62
hospitalized  neonates  with  suspected  septicemia,  9.8%  and
25.8% were  identified  as  positive  by  the  PCR method  using
16S rRNA genes, respectively [16]. In these studies in accor-
dance  with  our  report,  a  higher  rate  of  identification  of  bac-
teremia in comparison to blood culture has been reported [16,
17]. These results show that the molecular methods have higher
sensitivity and can detect lower levels of bacteria in the blood
samples in comparison to blood culture method. All techniques
have advantages and disadvantages. However using a culture
method,  multiple  bacterial  species  can  be  detected  simultan-
eously,  but  the  most  important  disadvantages  of  this  method
are: 1) it is time-consuming, 2) the bacterial species that are not
cultivable are eliminated, and 3) it is  incapable to identify bac-
Table 1. Association between the results of PCR assays and blood culture regarding patients factors.
P-Value
Blood Culture
P-Value
PCR
FactorsNegative,
N (%)
Positive,
N (%)
Negative,
N (%)
Positive,
N (%)
Age (years)
0.82 3 (1.1) 0 (0.0) 0.43 2 (0.8) 1 (0.3) 0-20
12 (4.5) 1 (0.3) 7 (2.7) 6 (2.3) 21-40
58 (21.9) 7 (2.7) 47 (17.7) 17 (6.4) 41-60
114 (43.0) 13 (4.9) 91 (34.3) 37 (14.0) 61-80
51 (19.3) 6 (2.3) 38 (14.3) 19 (7.2) 80-100
Gender
- 98 (36.9) 21 (7.9) - 99 (37.4) 46 (17.4) Male
140 (52.9) 6 (2.3) 86 (32.4) 34 (12.8) Female
Underlying disease
0.004* 37 (14.0) 10 (3.7) 0.1 29 (10.9) 17 (6.4) Diabetes mellitus
19 (7.2) 3 (1.1) 11 (4.1) 10 (3.8) Kidney failure
11 (4.1) 2 (0.8) 8 (3.1) 5 (1.9) Respiratory failure
24 (9.0) 6 (2.3) 18 (6.8) 12 (4.5) Infectious disease
12 (4.5) 2 (0.8) 1 1 (4.1) 3 (1.1) Malignancies
2 (0.8) 0 (0.0) 2 (0.8) 0 (0.0) Hospitalized infants in NICU
133 (50.2) 4 (1.5) 106 (40.0) 33 (12.5) Without underlying diseases
Prior antibiotic use
0.39 94 (35.4) 16 (6.1) < 0.001* 61 (23.0) 49 (18.5) With prior antibiotic use
144 (54.3) 11 (4.1) 124 (46.8) 31 (11.7) Without prior antibiotic use
* P ≤ 0.05 is significant.
Table 2. Association between the results of PCR assays and blood culture regarding laboratory data and clinical criteria of
the patients.
P-Value
Blood Culture
P-Value
PCR
Factor
Negative (Median Factors)
Positive
(Median Factors)
Negative
(Median Factors)
Positive
(Median Factors)
0.015* 10.5 13.0 0.018* 10.3 12.8 WBC
0.001* 23.0 53.0 0.003* 35.6 55.7 ESR
0.002* 38.3 38.6 0.05* 38.4 38.9 Fever
0.009* 45.1 77.3 0.001*˂ 39.8 68.2 CRP
* P ≤ 0.05 is significant.
104   The Open Microbiology Journal, 2019, Volume 13 Firoozeh et al.
teria  in  patients  who  have  taken  antibiotics.  Although  the
molecular  methods  do  not  have  the  mentioned  limitations,
these techniques specifically identify only a group of desired
bacterial species. Also, these methods generally need either the
use of multiple qPCRs or an additional sequencing step, which
leads to increased costs. Therefore, the molecular methods are
useful and complementary to the blood culture. The automated
molecular  techniques  have  high  value,  although  as  a  novel
approach,  the  interpretation  of  their  results  requires  more
experience  and  standardization.  Among  all  patients  with
positive blood culture, 3 of them had negative PCR results. As
there were no laboratory findings and clinical symptoms in two
of  these  three  cases,  and  also  the  isolated  bacteria  were
diagnosed  as  coagulase-negative  staphylococci,  the  positive
blood  culture  could  be  due  to  contamination  during  sample
collection.  Our  results  showed  that  the  previous  long-term
antibiotic use was a risk factor associated with bacteremia. This
finding  is  similar  to  other  researcher  findings  and  can  help
clinicians  to  consider  a  higher  probability  of  bacteremia  in
hospitalized  patients  who  have  received  longer  courses  of
antibiotic  therapy [18,  19].  A number of  studies  have shown
that  clinical  and  laboratory  diagnostic  criteria  such  as  fever,
WBC count, CRP and ESR are approved screening tests with
high sensitivity for the detection of sepsis [20]. A combination
of these tests and the molecular methods enhance the accuracy
of diagnosis of bacteremia [20]. Similar to other studies in this
context,  we  used  these  clinical  and  laboratory  criteria  as
predictive factors for the diagnosis of bacteremia. The findings
showed  that  fever,  WBC  count,  CRP  and  ESR  were  signi-
ficantly  higher  in  patients  with  bacteremia.  Isaacman  et  al.,
(1998)  have  used  the  PCR  and  blood  culture  methods  to
evaluate blood samples of patients with suspected bacteremia
and  showed  that  patients  with  positive  blood  culture  had  a
higher degree of fever and WBC count in comparison to blood
culture  negative  patients  regardless  of  PCR  results  [21].
Therefore  clinical  and laboratory  criteria,  especially  in  cases
where  the  results  of  cultures  and  molecular  methods  are  not
fully consistent, can be helpful in interpreting the results.
CONCLUSION
Finally, the findings of the present survey revealed that the
23S  rRNA  PCR  method  is  a  rapid  and  sensitive  technique
specially for the diagnosis of sepsis among patients in whom
bacteremia is difficult to diagnose with culture method inclu-
ding neonates and patients who have taken antibiotics before
microbial culture.
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